Literature DB >> 954003

Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro.

R H Himes, R N Kersey, I Heller-Bettinger, F E Samson.   

Abstract

The Vinca alkaloids differ in their chemotherapeutic effectiveness and their toxicities. To determine whether differences are due to a differential effect on the assembly of tubulin into microtubules, we examined the effects of vincristine, vinblastine, and a newer alkaloid, desacetyl vinblastine amide, on the assembly of bovine brain tubulin in vitro. The three compounds block bovine tubulin polymerization in vitro and almost equally effectively at a 1 muM concentration (tubulin, 6.5 muM). At 10 muM, the three alkaloids also interact with preformed microtubules in vitro, causing spiral-like distortions of the microtubules. No effect of the alkaloids on polymerization of another fibrous protein, actin, was observed. Thus the differential actions of vinblastine, vincristine, and desacetyl vinblastine amide in vivo seems to be based on some biological process other than the reaction with tubulin or the microtubules per se.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 954003

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

1.  Early embryonic development of the dipteran insect Heteropeza pygmaea in the presence of cytoskeleton-affecting drugs.

Authors:  Johannes Kaiser; Dirk F Went
Journal:  Rouxs Arch Dev Biol       Date:  1987-09

2.  Axotomy-induced ornithine decarboxylase activity in the mouse dorsal root ganglion is inhibited by the vinca alkaloids.

Authors:  A I Soiefer; A Moretto; P S Spencer; M I Sabri
Journal:  Neurochem Res       Date:  1988-12       Impact factor: 3.996

3.  Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine.

Authors:  M P Rivera-Fillat; J Pallarés-Trujillo; C Domènech; M R Grau-Oliete
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

4.  Vindesine. A short review of preclinical and first clinical data.

Authors:  R W Dyke; R L Nelson; W P Brade
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

5.  Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.

Authors:  Stefanie Geisler; Ryan A Doan; Amy Strickland; Xin Huang; Jeffrey Milbrandt; Aaron DiAntonio
Journal:  Brain       Date:  2016-10-25       Impact factor: 13.501

6.  Correlation of the clinical neurotoxicity of the vinca alkaloids vincristine, vinblastine, and vindesine with their effects on cultured rat midbrain cells.

Authors:  K L King; G B Boder
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

7.  Antitubulin activity of vinblastine and vincristine. Clinical implications of the radial segmentation test.

Authors:  G Simmingsköld; B Norberg; A Norberg; U B Söderström
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

8.  Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors.

Authors:  Chelsey Woodrum; Alison Nobil; Sandra L Dabora
Journal:  J Transl Med       Date:  2010-02-10       Impact factor: 5.531

9.  Differential in vitro action of S-12363, a new vinblastine derivative, and of its epimer on microtubule proteins.

Authors:  M Wright; M Garès; P Verdier-Pinard; A Moisand; M Berlion; J J Legrand; J P Bizzari
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

10.  Cytotoxic activity of tivantinib (ARQ 197) is not due solely to c-MET inhibition.

Authors:  Ryohei Katayama; Aki Aoyama; Takao Yamori; Jie Qi; Tomoko Oh-hara; Youngchul Song; Jeffrey A Engelman; Naoya Fujita
Journal:  Cancer Res       Date:  2013-04-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.